glutathione parkinsons & Parkinson's: Evidence, Biomarkers, Safety – PlexusDx glutathione therapy for parkinson& 39

10.1016/s0140-6736(16)32453-32459 Lancet 15 BuurmanR.GurlevikE.SchafferV.EilersM.SandbotheM.KreipeH.et al (2012)

TB-500 10mg Thymosin beta-4 analogue

In summary, this study provides strong evidence that hGMSCs possess both mesenchymal and neural differentiation potential, and that treatment with the Epitalon peptide significantly promotes neurogenic gene and protein expression

Both BPC-157 Acetate and Arginate appear as a white, lyophilized (freeze-dried) powder

Side Effects and Safety Both compounds have well-documented side effect profiles in the research literature

Medicina oxidativa y longevidad celular, 2017, 1716701